Using Ultrasound Compared to Standard Care to Detect Blood Loss After Cesarean Section A Randomized Study on Early Diagnosis of Postpartum Anemia

What this Trial Is About

Postpartum hemorrhage and anemia are major health concerns that can affect a mothers well-being and her bonding with her baby after delivery. This trial evaluates whether using ultrasound to check for blood loss after cesarean delivery can detect anemia earlier than standard care, which relies on blood tests measuring hemoglobin levels. Early detection is important because anemia can affect a mothers cognitive and emotional health, and untreated anemia may lead to complications such as postpartum depression and longer hospital stays. Participants are divided into two groups. One group receives abdominal and transvaginal ultrasound examinations within 24 to 48 hours after cesarean surgery to assess blood loss. The other group receives standard care without routine ultrasound. Ultrasound is a fast, non-invasive imaging method that can measure intra-abdominal fluid volume, which may indicate blood loss. The study compares these approaches to see which detects anemia sooner after delivery. Throughout the study, researchers will monitor hemoglobin drops within 24 to 72 hours postpartum and other ultrasound measurements such as uterine size and fluid volume. Additional assessments include infection rates, blood transfusions, hospital stay length, and maternal discomfort during ultrasound. Follow-up hemoglobin levels will also be checked 4 to 6 weeks after delivery. Participants will be closely monitored during the postpartum period to evaluate the timing and effectiveness of anemia diagnosis methods.

Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care